Veradigm (NASDAQ:MDRX) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX) in a research report sent to investors on Friday morning. The brokerage issued a hold rating on the software maker’s stock.

Veradigm Stock Down 1.5 %

Shares of MDRX opened at $9.26 on Friday. Veradigm has a 12 month low of $5.01 and a 12 month high of $13.62. The firm’s 50 day moving average is $9.51 and its 200-day moving average is $9.18.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in MDRX. Innealta Capital LLC bought a new position in shares of Veradigm during the second quarter worth approximately $38,000. Tyro Capital Management LLC bought a new position in Veradigm in the first quarter valued at approximately $9,055,000. Finally, Vanguard Group Inc. increased its stake in Veradigm by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock valued at $149,754,000 after acquiring an additional 95,291 shares during the last quarter.

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.